Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: J Thorac Oncol. 2014 Aug;9(8):1195–1201. doi: 10.1097/JTO.0000000000000228

Table 4.

Adjusted predictors of survival among patients treated with esophagectomy for cT2N0 esophageal cancer

Predictor Hazard ratio Lower 95% CI Upper 95% CI p-value
Induction therapy 1.16 0.87 1.56 0.32
Age (per decade) 1.22 1.06 1.40 0.005
Female sex 1.06 0.68 1.65 0.80
Race (ref = White)
Black 1.13 0.52 2.48 0.76
Other 1.14 0.39 3.34 0.81
Charlson/Deyo (0,1,2) 1.07 0.84 1.36 0.57
Squamous histology (vs. adenocarcinoma) 1.35 0.90 2.02 0.15
Pathologic Stage (per stage group) 1.61 1.33 1.94 <0.001
Education above median 1.05 0.73 1.50 0.80
Income above median 0.86 0.59 1.26 0.45
Facility volume (per 10 annual cases) 0.89 0.83 0.96 0.002